Viewing Study NCT02292758


Ignite Creation Date: 2025-12-25 @ 12:01 AM
Ignite Modification Date: 2026-02-19 @ 12:15 AM
Study NCT ID: NCT02292758
Status: COMPLETED
Last Update Posted: 2022-01-31
First Post: 2014-11-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Sponsor: Academic and Community Cancer Research United
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Adenocarcinoma View
None RAS Wild Type View
None Stage IV Colorectal Cancer AJCC v7 View
None Stage IVA Colorectal Cancer AJCC v7 View
None Stage IVB Colorectal Cancer AJCC v7 View
Keywords: